Gansu Provincial State-owned Asset Investment Group Co.,Ltd made a tender off to acquire a 38.37% stake in LanZhou Foci Pharmaceutical Co.,Ltd. (SZSE:002644) for CNY 1.8 billion on February 27, 2023. Under the terms, Gansu Provincial will pay CNY 9.60 per share in cash. China Dragon Securities Co., Ltd. acted as financial advisor and DeHeng Law Offices and acted as legal advisor to LanZhou Foci Pharmaceutical.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.89 CNY | -1.62% | +1.41% | -19.08% |
04-10 | Lanzhou Foci Pharmaceutical Chairman Resigns | MT |
04-10 | Lanzhou Foci Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-19.08% | 558M | |
+40.09% | 6.16B | |
-16.34% | 4.46B | |
-7.11% | 3.27B | |
+5.14% | 3.2B | |
-0.18% | 2.6B | |
+47.93% | 1.98B | |
-7.15% | 1.7B | |
+0.67% | 1.66B | |
-8.73% | 1.61B |
- Stock Market
- Equities
- 002644 Stock
- News LanZhou Foci Pharmaceutical Co.,Ltd.
- Gansu Provincial State-owned Asset Investment Group Co.,Ltd made a tender off to acquire a 38.37% stake in LanZhou Foci Pharmaceutical Co.,Ltd. for CNY 1.8 billion.